Mycophenolate mofetil. A useful immunosuppressive in inflammatory eye disease. (Q53937602)

22 May 2018

title

Mycophenolate mofetil. A useful immunosuppressive in inflammatory eye disease. (English)

1 reference

22 May 2018

0 references

G Larkin

1

1 reference

22 May 2018

S Lightman

series ordinal

2

1 reference

22 May 2018

publication date

1 February 1999

1 reference

22 May 2018

published in

Ophthalmology

1 reference

22 May 2018

volume

106

1 reference

22 May 2018

issue

2

1 reference

22 May 2018

page(s)

370-374

1 reference

22 May 2018

Causes and frequency of blindness in patients with intraocular inflammatory disease

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2899%2990078-7

7 January 2021

New therapeutic options in uveitis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2899%2990078-7

7 January 2021

Experimental approaches to specific immunotherapies in autoimmune disease: future treatment of endogenous posterior uveitis?

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2899%2990078-7

7 January 2021

Oral tolerance: immune mechanisms and treatment of autoimmune diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2899%2990078-7

7 January 2021

Mycophenolate mofetil (CellCept): immunosuppression on the cutting edge

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2899%2990078-7

7 January 2021

Mycophenolic acid in psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2899%2990078-7

7 January 2021

Mycophenolic acid for psoriasis. A review of pharmacology, long-term efficacy, and safety

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2899%2990078-7

7 January 2021

Bullous pemphigoid treated with mycophenolate mofetil

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2899%2990078-7

7 January 2021

Treatment of pemphigus vulgaris with mycophenolate mofetil

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2899%2990078-7

7 January 2021

Mycophenolate mofetil for severe autoimmune haemolytic anemia

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2899%2990078-7

7 January 2021

Inhibition of experimental autoimmune uveoretinitis by mycophenolate mofetil, an inhibitor of purine metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2899%2990078-7

7 January 2021

Immunosuppressive and other effects of mycophenolic acid and an ester prodrug, mycophenolate mofetil

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2899%2990078-7

7 January 2021

Mycophenolate mofetil

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2899%2990078-7

7 January 2021

A BLINDED, RANDOMIZED CLINICAL TRIAL OF MYCOPHENOLATE MOFETIL FOR THE PREVENTION OF ACUTE REJECTION IN CADAVERIC RENAL TRANSPLANTATION1

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2899%2990078-7

7 January 2021

10.1016/S0161-6420(99)90078-7

Identifiers

DOI

1 reference

22 May 2018

PubMed ID

9951492

1 reference

22 May 2018